Search results
Home Blood Pressure Monitoring
Author(s):
Jacob George
,
Thomas M MacDonald
Added:
3 years ago
Article
Author(s):
John Anderson
,
Nicola Donnelly
Added:
3 years ago
A range of treatments have been developed for the management of cardiac arrhythmias. These include antiarrhythmic drugs, artificial pacemakers, implanted cardiac defibrillators and ablation of damaged or malfunctioning cardiac tissue. However, to allow a physician to choose the most suitable course of treatment for a patient, it is important that the correct diagnosis be made in an appropriate…
View more
Author(s):
Harry Crijns
Added:
3 years ago
Atrial fibrillation (AF), the most common type of arrhythmia, is a rapid uncoordinated generation of electrical impulses by the atrial chambers of the heart. Its prevalence increases with age from less than 1% in people aged <60 years to 10% in individuals aged >80 years. AF is a powerful independent risk factor for stroke and mortality, conferring a five-fold and 1.5- to 1.9-fold increase…
View more
Author(s):
Matthew McKillop
Added:
1 year ago
HRX 22 - Dr Matthew McKillop from ReadmyRhythm joins us to outline a new wearable heart monitoring platform to identify and diagnose cardiac arrhythmias in users.
Questions:
1. What are the clinical unmet needs that led to the creation of this technology?
2. What is ReadmyRhythm?
3. What is the data underpinning the use of this technology, and what future study is planned?
4. How can this…
View more
Author(s):
Jose Luis Zamorano
Added:
3 years ago
Heart failure (HF) is a growing and increasingly important chronic disease of the Western world, occurring in at least 2% of the adult population and rising to 3% in those aged over 75 years. It is characterised by inadequate systemic perfusion due to impairment of the cardiac pump function. Clinical HF is a progressive condition, typically with high morbidity and mortality rates. It therefore…
View more
Author(s):
Jose Luis Zamorano
Added:
3 years ago
Heart failure (HF) is a growing and increasingly important chronic disease of the Western world, occurring in at least 2% of the adult population and rising to 3% in those aged over 75 years.1 It is characterised by inadequate systemic perfusion due to impairment of the cardiac pump function. Clinical HF is a progressive condition, typically with high morbidity and mortality rates. It therefore…
View more
Author(s):
Bosede A Afolabi
,
Fred M Kusumoto
Added:
3 years ago
Since the first implantable pacemaker was introduced in 1958, electronic devices designed to treat cardiac problems have experienced technological leaps. A rapidly expanding number of patients depend on this technology.1 Cardiovascular implantable electronic devices (CIEDs) now include implantable cardioverter defibrillators (ICDs), pacemakers (PMs), cardiac resynchronisation therapy (CRT)…
View more
Author(s):
Juan Caro Codón
Added:
11 months ago
EHRA 2023 — Dr Juan Caro Codón (La Paz University Hospital, Madrid, ES) discusses the findings from the TEMPO-HCM study investigating extended ECG monitoring in hypertrophic cardiomyopathy (HCM) patients.
This was a prospective, observational, multicenter trial that included patients with a diagnosis of hypertrophic cardiomyopathy. Investigators compared the rate of clinically relevant…
View more
Author(s):
Jasper J Brugts
Added:
10 months ago
ESC-HFA 2023 — Dr Jasper Brugts (Thoraxcenter, NL) joins us to outline the findings and summarise the take-home messages from the MONITOR-HF trial (NTR7672).
MONITOR-HF was an open-label, randomised trial, done in 25 centres in the Netherlands. Eligible patients had chronic heart failure of New York Heart Association class III and a previous heart failure hospitalisation, irrespective of…
View more
Implantable Cardiac Monitoring
Author(s):
Jan Steffel
,
,
Start date:
Sep 23, 2021
Broadcast